Pharmacotherapy for treatment of attention deficits after non-progressive acquired brain injury. A systematic review

Clinical Rehabilitation

Volumn 24, Issue 2, 2010, Pages 110-121

  Sivan, Manoj ^a   Neumann, Vera ^a   Kent, Ruth ^a   Stroud, Amanda ^b   Bhakta, Bipinchandra B ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ATTENTION; BRAIN INJURY; DRUG EFFECT; HUMAN; PATHOPHYSIOLOGY; REVIEW;

ADULT; ATTENTION; BRAIN INJURIES; HUMANS;

EID: 75949128670     PISSN: 02692155     EISSN: 14770873     Source Type: Journal    
DOI: 10.1177/0269215509343234     Document Type: Review

References (36)

1. Cohen JD, Aston-Jones G., Gilzenrat MS A systems-level perspective on attention and cognitive control. In Posner MI ed. Cognitive neurosciences of attention. New York: Guilford Press, 2004: 71-90.
2. Warden DL, Gordon B., McAllister TW et al. Neurobehavioral Guidelines Working Group. Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury. J Neurotrauma 2006 ; 23: 1468-1501.
3. Pierce SR, Buxbaum LJ Treatments of unilateral neglect: a review. Arch Phys Med Rehabil 2002 ; 83: 256-268.
4. Sohlberg MM, Mateer CA Cognitive rehabilitation, an integrative neuropsychological approach. New York: Guilford Press, 2001.
5. Bellgrove MA, Dockree PM, Aimola L., Robertson IH Attenuation of spatial attentional asymmetries with poor sustained attention. Neuroreport 2004 ; 15: 1065-1069.
6. Hjaltason H., Tegnr R., Tham K., Levander M., Ericson K. Sustained attention and awareness of disability in chronic neglect. Neuropsychologia 1996 ; 34: 1229-1233.
7. Michel JA, Mateer CA Attention rehabilitation following stroke and traumatic brain injury. Eura Medicophys 2006 ; 42: 59-67.
8. Raz A. Anatomy of attentional networks. Anat Rec B New Anat 2004 ; 281: 21-36.
9. Flanagan SR, Kane L., Rhoades D. Pharmacological modification of recovery following brain injury. J Neurol Phys Ther 2003 ; 3: 129-137.
10. Bullock R., Chesnut RM, Clifton G. et al. Guidelines for the management of severe head injury. Brain Trauma Foundation. Eur J Emerg Med 1996 ; 3: 109-127.
11. Whyte J., Hart T., Schuster K., Fleming M., Polansky M., Coslett HB Effects of methylphenidate on attentional function after traumatic brain injury. A randomized, placebo-controlled trial. Am J Phys Med Rehabil 1997 ; 76: 440-450.
12. Whyte J., Hart T., Vaccaro M. et al. Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial. Am J Phys Med Rehabil 2004 ; 83: 401-420.
13. Mooney GF, Haas LJ Effect of methylphenidate on brain injury-related anger. Arch Phys Med Rehabil 1993 ; 74: 153-160.
14. Kim YH, Ko MH, Na SY, Park SH, Kim KW Effects of single-dose methylphenidate on cognitive performance in subjects with traumatic brain injury: a double-blind placebo-controlled study. Clin Rehabil 2006 ; 20: 24-30.
15. Lee H., Kim SW, Kim JM, Shin IS, Yang SJ, Yoon JS Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in subjects with traumatic brain injury. Hum Psychopharmacol 2005 ; 20: 97-104.
16. Plenger PM, Dixon CE, Castillo RM, Frankowski RF, Yablon SA, Levin HS Sub-acute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study. Arch Phys Med Rehabil 1996 ; 77: 536-540.
17. Kaelin DL, Cifu DX, Matthies B. Methylphenidate effect on attention deficit in the acutely brain-injured adult. Arch Phys Med Rehabil 1996 ; 77: 6-9.
18. Speech TJ, Rao SM, Osmon DC, Sperry LT A double-blind controlled study of methylphenidate treatment in closed head injury. Brain Inj 1993 ; 7: 333-338.
19. Gualtieri CT, Evans RW Stimulant treatment for the neurobehavioural sequelae of traumatic brain injury. Brain Inj 1988 ; 2: 273-290.
20. Grade C., Redford B., Chrostowski J., Toussaint L., Blackwell B. Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study. Arch Phys Med Rehabil 1998 ; 79: 1047-1050.
21. Hornstein A., Lennihan L., Seliger G., Lichtman S., Schroeder K. Amphetamine in recovery from brain injury. Brain Inj 1996 ; 10: 145-148.
22. Meythaler JM, Brunner RC, Johnson A., Novack TA Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial. J Head Trauma Rehabil 2002 ; 17: 300-313.
23. Schneider WN, Drew-Cates J., Wong TM, Dombovy ML Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: an initial double-blind placebo-controlled study. Brain Inj 1999 ; 13: 863-872.
24. Buxbaum LJ, Ferraro M., Whyte J., Gershkoff A., Coslett HB Amantadine treatment of hemispatial neglect: a double-blind, placebo-controlled study. Am J Phys Med Rehabil 2007 ; 86: 527-537.
25. Kraus MF, Smith GS, Butters M. et al. Effects of the dopaminergic agent and NMDA receptor antagonist amantadine on cognitive function, cerebral glucose metabolism and D2 receptor availability in chronic traumatic brain injury: a study using positron emission tomography (PET). Brain Inj 2005 ; 19: 471-479.
26. Kraus MF, Maki PM Effect of amantadine hydrochloride on symptoms of frontal lobe dysfunction in brain injury: case studies and review. J Neuropsychiatry Clin Neurosci 1997 ; 9: 222-230.
27. Nickels JL, Schneider WN, Dombovy ML, Wong TM Clinical use of amantadine in brain injury rehabilitation. Brain Inj 1994 ; 8: 709-718.
28. Gualtieri T., Chandler M., Coons TB, Brown LT Amantadine: a new clinical profile for traumatic brain injury. Clin Neuropharmacol 1989 ; 12: 258-270.
29. Mukand JA, Guilmette TJ, Allen DG et al. Dopaminergic therapy with carbidopa L-dopa for left neglect after stroke: a case series. Arch Phys Med Rehabil 2001 ; 82: 1279-1282.
30. Whyte J., Vaccaro M., Grieb-Neff P., Hart T., Polansky M., Coslett HB The effects of bromocriptine on attention deficits after traumatic brain injury: a placebo-controlled pilot study. Am J Phys Med Rehabil 2008 ; 87: 85-99.
31. Fleet WS, Valenstein E., Watson RT, Heilman KM Dopamine agonist therapy for neglect in humans. Neurology 1987 ; 37: 1765-1770.
32. Zhang L., Plotkin RC, Wang G., Sandel ME, Lee S. Cholinergic augmentation with donepezil enhances recovery in short-term memory and sustained attention after traumatic brain injury. Arch Phys Med Rehabil 2004 ; 85: 1050-1055.
33. Khateb A., Ammann J., Annoni JM, Diserens K. Cognition-enhancing effects of donepezil in traumatic brain injury. Eur Neurol 2005 ; 54: 39-45.
34. Levin HS, Peters BH, Kalisky Z. et al. Effects of oral physostigmine and lecithin on memory and attention in closed head-injured subjects. Cent Nerv Syst Trauma 1986 ; 3: 333-342.
35. Cardenas DD, McLean Jr A., Farrell-Roberts L., Baker L., Brooke M., Haselkorn J. Oral physostigmine and impaired memory in adults with brain injury. Brain Inj 1994 ; 8: 579-587.
36. Levin HS Treatment of postconcussional symptoms with CDPcholine. J Neurol Sci 1991 ; 103: S39 - S42.